Recommendations on ODA eligibility of spending related to Covid-19 vaccines
As some Development Assistance Committee (DAC) donors are considering using their Official Development Aid (ODA) budgets to cover expenditures related to Covid-19 vaccines, the work of the DAC is critical to ensure that ODA eligibility rules uphold ODA’s integrity and credibility, prevent an artificial inflation in ODA budgets, and avoid unduly valorising donor countries for a behaviour that exacerbated vaccine inequality in the first place.
We appreciate the DAC’s efforts to consult with civil society organisations on these issues, including through a meeting with the DAC Working Party on Development Finance Statistics (WP-STAT) in May and an expert workshop in June. With this paper, we share our positions on ODA eligibility regarding in particular Covid-19 R&D and vaccine dose donations. We look forward to further elaborating and exchanging on these points in the months to come, as the DAC makes progress in deliberating on these issues. Read the full statement below.
Do you need more information?
-
Irene Schipper
Senior Researcher
Download
Related news
-
-
Big Pharma raked in USD 90 billion in profits with COVID-19 vaccinesPosted in category:NewsEsther de HaanPublished on:
-
Pharma’s pandemic profits Published on:Esther de HaanPosted in category:PublicationEsther de Haan